Net Loss per Common Share

9 Months Ended

Sep. 30, 2019

(11)	Net Loss per Common Share

Basic net loss per share is determined by dividing net loss by the weighted average shares of common stock outstanding during the period, without consideration of potentially dilutive securities except for those shares that are issuable for little or no cash consideration. Diluted net loss per share is determined by dividing net loss by diluted weighted average shares outstanding. Diluted weighted average shares reflects the dilutive effect, if any, of potentially dilutive common shares, such as stock options and warrants calculated using the treasury stock method. In periods with reported net operating losses, all common stock options and warrants are generally deemed anti-dilutive such that basic net loss per share and diluted net loss per share are equal. However, in certain periods in which the exercise price of the warrants was less than the last reported sales price of Delcath’s common stock on the final trading day of the period and there is a gain recorded pursuant to the change in fair value of the warrant derivative liability, the impact of gains related to the mark-to-market adjustment of the warrants outstanding at the end of the period is reversed and the treasury stock method is used to determine diluted earnings per share.

	Three months ended September 30,						Nine months ended September 30,
(in thousands, except share data)	2019			2018			2019			2018
Net (loss) income - basic	$	(7,519	)	$	(8,880	)	$	(21,371	)	$	(8,353	)
Preferred stock dividends		(18,238	)		—			(18,238	)		—
Adjustment for gain on warrant income		—			(13	)		—			(534	)
Net loss - diluted	$	(25,757	)	$	(8,893	)	$	(39,609	)	$	(8,887	)

Weighted average shares outstanding - basic*		18,277,807			35,859,866			16,166,307			13,888,577
Weighted average shares outstanding - diluted*		18,277,807			35,859,866			16,166,307			13,888,587

Net loss per share - basic*	$	(0.41	)	$	(0.25	)	$	(1.32	)	$	(0.60	)
Net loss per share - diluted*	$	(1.41	)	$	(0.25	)	$	(2.45	)	$	(0.64	)

*reflects a one-for-five hundred (1:500) reverse stock split effected on May 2, 2018.

As discussed in Note 9, the Series E Preferred Stock and the Series E-1 Preferred Stock were each determined to have a beneficial conversion feature which was accounted for as a deemed dividend.

The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2019 and 2018 because their effects would be anti-dilutive:

	September 30,
	2019		2018
Stock options		1,150,000		—
Common stock warrants - equity		—		4,202,909
Common stock warrants - liability		701,373,599		1,000,011
Assumed conversion of Series E and E-1 Preferred Stock		701,373,570		—
Assumed conversion of convertible notes		22,222,222		5,639,318
Total		1,426,119,391		10,842,238